Thymic selection adjusts the reactivity of the peripheral T cell repertoire to maximize recognition of pathogens and minimize stimulation by innocuous substances and self-antigen. The study of molecules implicated in T cell activation often involves the generation of knockout (؊͞؊) mice. In many instances, knockout animals display revealing phenotypes. But should a lack of phenotype be interpreted as a lack of function? Bcl-x␥ was shown previously to affect T cell activation in vitro, and here we note that overexpression of this molecule increases cell cycling after T cell receptor ligation by antibody. It was therefore surprising that Bcl-x␥ ؊/؊ , Bcl-x␥ transgenic, and WT T cells displayed similar levels of sensitivity to antigen according to ex vivo stimulation. Bcl-x␥ could be demonstrated to influence competitiveness and selection of thymocytes in a manner that counteracted the effects of Bcl-x␥ mutation on T cell activation. These findings suggest that thymic selection can overcome genetic defects in T cell activation to generate a T cell repertoire of normal reactivity.
Thymic selection adjusts the reactivity of the peripheral T cell repertoire to maximize recognition of pathogens and minimize stimulation by innocuous substances and self-antigen. The study of molecules implicated in T cell activation often involves the generation of knockout (؊͞؊) mice. In many instances, knockout animals display revealing phenotypes. But should a lack of phenotype be interpreted as a lack of function? Bcl-x␥ was shown previously to affect T cell activation in vitro, and here we note that overexpression of this molecule increases cell cycling after T cell receptor ligation by antibody. It was therefore surprising that Bcl-x␥ ؊/؊ , Bcl-x␥ transgenic, and WT T cells displayed similar levels of sensitivity to antigen according to ex vivo stimulation. Bcl-x␥ could be demonstrated to influence competitiveness and selection of thymocytes in a manner that counteracted the effects of Bcl-x␥ mutation on T cell activation. These findings suggest that thymic selection can overcome genetic defects in T cell activation to generate a T cell repertoire of normal reactivity.
Bcl-x␥ ͉ TCR ͉ thymus ͉ CD5
T he T cell repertoire has evolved to provide optimal reactivity to antigenic stimuli. Its sensitivity is a compromise between maximal recognition of pathogenic organisms and minimal reactivity against innocuous substances and self-antigens. This fine balance is set during the process of thymic selection (1) , when each T cell's chance of survival and maturation is dictated by the affinity of its T cell receptor (TCR) for MHC molecules presenting self-antigen. In addition to the TCR itself, many costimulatory and accessory molecules determine the outcome of a T cell's encounter with MHC͞peptide complexes. A classic approach to determining the contribution of each of these molecules to T cell activation is to study the response of T cells from genetic knockout (Ϫ͞Ϫ) mice that are deficient in particular gene products secondary to targeted gene mutation. In some cases, the effect is dramatic, leading to severe lymphoproliferation and death in the case of CTLA-4 Ϫ/Ϫ mice for example (2) . In other instances, such as in CD5 Ϫ/Ϫ mice, no obvious defect or anomaly is observed (3). Manipulating molecules that are essential to the regulation of T cell activity can generally be expected to generate clear phenotypes. But should molecules whose absence does not appear to affect T cell reactivity be dismissed as nonessential or redundant? Or could adjustments of T cell reactivity imposed by intrathymic selection compensate for mutational abnormalities in T cell activation and thus mask a class of knockout phenotypes?
Bcl-x␥ is a T cell-specific isoform of Bcl-x that is up-regulated after T cell activation (4) . Despite its very close genetic and molecular relationship to the well characterized Bcl-xL, Bcl-x␥ does not appear to be involved directly in the regulation of apoptosis (5) . Instead, this molecule affects T cell cycling and proliferation by an as-yet-undetermined mechanism. We have previously shown that Bcl-x␥ Ϫ/Ϫ T cells are hyporesponsive to antibody-dependent TCR ligation. Conversely, overexpression of Bcl-x␥ enhanced in vitro T cell responses to anti-CD3 or peptide antigen when TCR transgenic (Tg) cells were used (5).
In addition, Bcl-x␥ Ϫ/Ϫ mice seemed relatively resistant to the induction of experimental autoimmune encephalomyelitis (EAE) (5) . However, further investigation of the role of Bcl-x␥ in T cell activation indicated that forced overexpression of Bcl-x␥ did not alter in vivo responses compared with WT littermates. Because Bcl-x␥ is expressed after TCR stimulation, and appears to be transiently expressed during T cell development, namely at the double-positive (DP) stage (4), we assessed whether loss or overexpression of Bcl-x␥ may be compensated through altered T cell repertoire selection. Our results suggest that altered intrathymic development and selection can blunt the impact of dysregulated Bcl-x␥ expression and thus undo the phenotypic consequences of certain genetic mutations in mature T cells. and Bcl-x␥ Tg mice were generated in our laboratory (5) and backcrossed onto C57BL͞6 background for at least six generations. 2D2 mice, which express a Tg TCR specific for a myelin oligodendrocyte glycoprotein peptide (MOG 35-55) (6) (kind gift from E. Bettelli CFSE Labeling and Division History Analysis. T cells were isolated from lymph nodes by magnetic separation [negative selection, using anti-B220, anti-CD8, anti-Gr1, anti-Mac-1, and anti-NK1.1 rat antibodies (BD Pharmingen) followed by anti-rat magnetic beads (Dynal, Great Neck, NY) to deplete all other cells] and stained with 2 M CFSE (Sigma) solution at 37°C for 15 min before being washed. Cells were then stimulated in vitro by using anti-CD3 and anti-CD28 (BD Pharmingen). Alternatively, cells were injected into RAG-2 Ϫ/Ϫ recipients i.v. At the indicated time point, cells from in vitro cultures or isolated lymph nodes were stained for cell-surface markers (CD4 and͞or CD3, BD Pharmingen) for flow cytometric analysis (Coulter) of CFSE dilution.
Materials and Methods
mg͞ml MOG 35-55 and 2 mg͞ml Mycobacterium tuberculosis. In addition, 200 ng of Pertussis toxin was injected i.p. on the day of immunization and 2 days later. Mice were monitored daily, and scores were assessed as follows: 1, limp tail; 2, impaired righting reflex͞hind limb weakness; 3, hind limb paralysis; 4, hind and fore limb paralysis; 5, moribund or dead. Generation and Analysis of Mixed Bone Marrow (BM) Chimeras. BM of indicated genotypes was isolated from femur, tibia, and humerus bones, and magnetically depleted of T and B lymphocytes by using purified rat B220 and CD3 antibodies (BD Pharmingen) and anti-rat antibody coupled to magnetic beads (Dynal). After counting the remaining cells, BM cells were mixed in a 1:1 ratio as indicated, and 3 ϫ 10 6 cells of this mixture were injected i.v. into irradiated (1,000 rad) Rag-2 Ϫ/Ϫ recipients. Four weeks later, thymus, spleen, and lymph nodes were isolated, and cells were stained with fluorochrome-conjugated anti-CD4, anti-CD8, anti-CD25, and anti-CD5 antibodies (BD Pharmingen) as indicated. Stained cells were analyzed by flow cytometry (Coulter). Results are given as mean Ϯ SEM of percentages from all individual mice for the indicated group. For CD5 levels, mean fluorescence intensity is shown for each mouse.
Statistical Analyses. All statistical analyses were performed with PRISM data analysis software (GraphPad, San Diego).
Results and Discussion

Overexpression of Bcl-x␥ Enhances Cell Cycling in Vitro but Fails to
Increase EAE Disease Severity in Vivo. Previous work from our laboratory (5) showed that the loss of Bcl-x␥ attenuated T cell responses in vitro after antibody-dependent CD3 ligation. Conversely, overexpression of this molecule increased proliferative responses. We attempted to further explore the functional basis for these effects on T cell activation. Analysis of division history of CFSE-labeled WT or Bcl-x␥ Tg T cells after anti-CD3 stimulation indicated that Bcl-x␥ overexpression increased the number of divisions that T cells underwent after CD3 ligation, in the presence or absence of anti-CD28 ( Fig. 1 A and B) .
We subsequently analyzed the lymphopenia-induced expansion of CFSE-labeled T cells from Bcl-x␥ Ϫ/Ϫ , WT, or Tg donors in vivo by transfer into RAG-2 Ϫ/Ϫ hosts. T cells of all genotypes had divided up to five times after 1 week, and no differences among these populations were observed (data not shown). Antigen-induced activation in vivo was also examined by immunization of Bcl-x␥ Tg and WT mice with myelin oligodendrocyte glycoprotein-derived peptide (MOG 35-55) to induce EAE. Although Bcl-x␥ Ϫ/Ϫ mice are resistant to a milder form of EAE induced by proteolipid protein (PLP), MOG-induced disease was no more severe in Bcl-x␥ Tg mice than in WT littermates (Fig. 1C) . In addition, when EAE was induced in CD28 Ϫ/Ϫ animals of either Bcl-x␥ Tg or WT genotype, both groups displayed similar resistance to disease (Fig. 1D) .
Dysregulation of Bcl-x␥ Expression Does Not Affect Tolerogenic or
Immunogenic Responses to Peptide Antigen in Vivo. Peptide-induced tolerance is thought to be, in part, due to the incomplete activation of peptide-specific T cells (8) Fig. 2A) . Not only did the overexpression of Bcl-x␥ fail to prevent tolerance induction, but Bcl-x␥ Tg T cells appeared to respond in identical fashion to WT cells after antigen priming.
A possible explanation for the lack of hyperreactivity in the Tg population may be that the TCR usage of these cells differed from that of WT cells to adjust to the strength of signaling. We decided to further investigate whether a form of T cell tuning (9) underlies these unexpected results. After immunization with MOG 35-55 peptide, the in vitro responses of draining lymph nodes from Bcl-x␥ Ϫ/Ϫ and WT mice were indistinguishable (Fig.  2B) . However, when MOG-responsive TCR Tg mice (2D2 mice) (6) were used, Bcl-x␥ Ϫ/Ϫ cells were hyporesponsive to this peptide compared to WT 2D2 T cells, both before (Fig. 2C ) and after (data not shown) peptide immunization. Immunization of 2D2 WT mice with MOG 35-55 peptide also induced increased CD4 ϩ T cell numbers in draining lymph nodes compared to 2D2 Bcl-x␥ Ϫ/Ϫ mice (P ϭ 0.0477, n ϭ 4; data not shown). In this case, Bcl-x␥ deficiency could not be compensated for by an altered TCR repertoire. That is, because T cells from both 2D2 Bclx␥ Ϫ/Ϫ and 2D2 WT mice expressed the same TCR, the TCR repertoire could not be adjusted to tune the response to peptide.
Bcl-x␥ Expression Levels Modulate Competitiveness of T Cells During
Thymic Maturation. Bcl-x␥ is expressed after TCR stimulation (4) and is not detected in resting peripheral T cells. However, Bcl-x␥ expression is up-regulated during thymic maturation and is readily detectable in DP thymocytes (4). This up-regulation is a consequence of TCR͞MHC interactions during selection processes, because DP thymocytes from mice deficient in both MHC class I and II molecules fail to express Bcl-x␥ (4). We have previously shown that thymic and peripheral T cell populations are normal in terms of size and distribution in both Bcl-x␥ Ϫ/Ϫ and Bcl-x␥ Tg mice (5) . In view of the above findings that dysregulation of Bcl-x␥ expression may alter the TCR repertoire, we tested the effects of Bcl-x␥ deficiency and overexpression on thymic selection.
To design a system that would provide sensitive detection of anomalies during thymic maturation of T cells, we generated mixed BM chimeras. Bcl-x␥ Tg mice were crossed with T-GFP mice (7) (kind gift from U. von Andrian). Mixtures of equal parts of BM from Bcl-x␥ Tg T-GFP and Bcl-x␥ (Fig. 3A) . The double-negative stage was not analyzed, because GFP is under the control of the CD4 promoter (in the absence of the intronic silencer) and is not expressed at this developmental stage. Analysis of the DP thymic compartment revealed that Bcl-x␥ Tg T cells made up 75% of this population ( (Fig. 3C) . The finding that Bcl-x␥ deficiency may favor maturation of high-affinity T cells compared to Bcl-x␥ Tg cells is consistent with the idea that the TCR repertoire in each population is predictably shifted. We further tested this hypothesis by generating 2D2 TCR Tg mixed BM chimeras (Fig. 3D) . 2D2 Bcl-x␥ Ϫ/Ϫ cells were again at a disadvantage compared to 2D2 Bcl-x␥ WT T-GFP cells at the DP stage, consistent with observations made when using polyclonal T cells. However, in this case, Bcl-x␥-dependent disequilibrium was carried through thymic maturation into peripheral T cells. The finding that Bcl-x␥ WT lineage was overrepresented in both CD4 SP thymocytes and peripheral CD4 T cells suggests that compensation for Bcl-x␥ deficiency requires selection among clones within a polyclonal TCR repertoire. overexpress Bcl-x␥ even if their TCR affinity would not suffice for survival with normal levels of Bcl-x␥. A second implication is increased negative selection of those cells with relatively high affinity that are more efficiently deleted because of Bcl-x␥ overexpression. Although these two effects of Bcl-x␥ overexpression would tend to counteract each other in terms of the overall numbers of cells progressing through thymic selection, two predicted and testable outcomes of Bcl-x␥ overexpression are (i) higher numbers of negatively selected cells in Bcl-x␥ Tg mice and (ii) increased numbers of low-affinity DP and SP thymocytes.
To assess the susceptibility of Bcl-x␥ Tg DP thymocytes to deletion, mice were injected with anti-CD3 (Fig. 4A) . The antibody-dose administered was suboptimal for deletion of WT DP thymocytes but very efficiently deleted Bcl-x␥ Tg DP cells, supporting the idea that overexpression of Bcl-x␥ may enhance negative selection. We then tested the prediction that Bcl-x␥ overexpression would increase the proportion of thymocytes with relatively low affinity for self-MHC. We generated BM chimeric mice that lacked class I MHC in the hematopoietic compartment, because previous studies have indicated that class I-dependent positive selection by hematopoietic cells is relatively inefficient and consequently selects TCRs that exhibit highavidity interactions with self-MHC ligands in the thymus (11) . This set of chimeras was produced after injection of BM from WT, Bcl-x␥ Tg, ␤ 2 m
Bcl-x␥ Tg mice into irradiated syngeneic mice.
CD5 is thought to have a negative regulatory function and to adjust the reactivity of T cells (12, 13) . Further, it is believed that CD5 expression, induced at the DP stage after TCR signals that drive positive selection (14, 15) , directly correlates with the affinity of the TCR (16, 17) . CD8 SP cells from ␤ 2 m Ϫ/Ϫ Bcl-x␥ Tg chimeras displayed lower levels of CD5 than cells of ␤ 2 m Ϫ/Ϫ Bcl-x␥ WT mice (Fig. 4C) . Interestingly, differences in CD5 expression levels were first noted at the DP stage (Fig. 4D) . (18) . In either case, the more stringent conditions imposed by hematopoietic MHC I deficiency suffice to unmask Bcl-x␥ Tg T cells that have been allowed to undergo positive selection but are marked by the surface CD5 phenotype characteristic of low-avidity cells.
Concluding Remarks. We have previously shown that Bcl-x␥ affects T cell reactivity in vitro in response to antibody, and to antigen when TCR Tg T cells were used (5) . Here, we extend these findings and demonstrate that overexpression of Bcl-x␥ increases cell cycling after CD3 ligation. However, in vivo responses to antigen seemed unaffected by dysregulated expression of this Bcl-x family molecule. The peripheral repertoire of Bcl-x␥ Ϫ/Ϫ and Bcl-x␥ Tg mice displayed reactivities similar to that of WT mice. These apparently contradictory results were resolved, in part, by analysis of thymic selection of genetically modified T cells: experiments with mixed BM chimeras revealed that dysregulated Bcl-x␥ expression affected the competitiveness of developing thymocytes and most probably influenced TCR repertoire selection. Although development of Bcl-x␥ Ϫ/Ϫ cells was impaired in competition with Bcl-x␥ Tg cells, this disadvantage could be compensated by selection processes that masked any effect on the resulting mature T cell pool. In contrast, no compensation took place in TCR Tg BM chimeras, presumably reflecting the need for a diverse repertoire of TCR for Bcl-x␥ Ϫ/Ϫ cells to effectively compete with WT or Bcl-x␥ Tg cells during selection. The composition of the CD4 ϩ CD25 ϩ population in chimeric mice with a polyclonal TCR repertoire differed from that of CD4 ϩ CD25 Ϫ cells, further suggesting that the loss of Bcl-x␥ may improve the chances of maturation of cells expressing high-affinity TCR.
Finally, overexpression of Bcl-x␥ facilitated deletion of DP thymocytes after anti-CD3 injection and allowed positive selection of an expanded population of CD5 lo thymocytes in ␤ 2 m Ϫ/Ϫ BM chimeras. Together, these results indicate that modulation of Bcl-x␥ expression has a significant impact on T cell selection. The recursive nature of thymic selection, however, led to peripheral T cells of normal reactivities despite the demonstrated impact of dysregulated Bcl-x␥ expression on T cell activation. In addition to providing an explanation for the lack of phenotypic changes in Bcl-x␥ Ϫ/Ϫ and Bcl-x␥ Tg mice, these findings strongly suggest that thymic selection is more generally capable of covering up genetic deficiencies by selecting a T cell repertoire of appropriate reactivity, independently of defects in T cell activation. In CD5 Ϫ/Ϫ mice, thymocytes were found to be hyperreactive, for example, but the reactivity of the peripheral T cell compartment was normal (12) . We would postulate that the absence of CD5 has effects on TCR repertoire selection similar to those observed in our system. We also suggest that despite the undoubted importance of targeted mutagenesis in understanding the genetic basis of T cell activation, blunted or undetectable phenotypic changes may in some cases reflect the flexibility of the selection processes, as described here.
